Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Organon & Co (NYSE: OGN) closed at $9.98 in the last session, down -0.20% from day before closing price of $10.0. In other words, the price has decreased by -$0.20 from its previous closing price. On the day, 2.54 million shares were traded. OGN stock price reached its highest trading level at $10.18 during the session, while it also had its lowest trading level at $9.9519.
Ratios:
We take a closer look at OGN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.34. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.67. In the meantime, Its Debt-to-Equity ratio is 16.52 whereas as Long-Term Debt/Eq ratio is at 16.49.
On September 06, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also upped its target price recommendation from $18 to $20.
Goldman Downgraded its Buy to Neutral on November 03, 2023, whereas the target price for the stock was revised from $33 to $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when COX CARRIE SMITH bought 12,469 shares for $8.07 per share. The transaction valued at 100,591 led to the insider holds 12,469 shares of the business.
Falcione Aaron bought 5,500 shares of OGN for $48,235 on May 07 ’25. The Chief Human Resources Officer now owns 62,974 shares after completing the transaction at $8.77 per share. On May 06 ’25, another insider, Weaver Kirke, who serves as the Gen. Counsel & Corp. Secy. of the company, bought 8,045 shares for $9.21 each. As a result, the insider paid 74,054 and bolstered with 52,489 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OGN now has a Market Capitalization of 2599560192 and an Enterprise Value of 11003361280. As of this moment, Organon’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.45, and their Forward P/E ratio for the next fiscal year is 2.44. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.90. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.41 while its Price-to-Book (P/B) ratio in mrq is 4.75. Its current Enterprise Value per Revenue stands at 1.748 whereas that against EBITDA is 6.492.
Stock Price History:
The Beta on a monthly basis for OGN is 0.56, which has changed by -0.51787436 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, OGN has reached a high of $23.10, while it has fallen to a 52-week low of $8.01. The 50-Day Moving Average of the stock is 1.25%, while the 200-Day Moving Average is calculated to be -31.26%.
Shares Statistics:
According to the various share statistics, OGN traded on average about 5.68M shares per day over the past 3-months and 3498490 shares per day over the past 10 days. A total of 259.96M shares are outstanding, with a floating share count of 258.99M. Insiders hold about 0.37% of the company’s shares, while institutions hold 80.32% stake in the company. Shares short for OGN as of 1749772800 were 15952116 with a Short Ratio of 2.81, compared to 1747267200 on 15960972. Therefore, it implies a Short% of Shares Outstanding of 15952116 and a Short% of Float of 8.180001.
Dividends & Splits
The forward annual dividend rate for OGN is 0.86, which was 1.12 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.112
